Glasgow, SCOTLAND. Sistemic Ltd. announced today that it had signed an agreement with Roslin Cells Ltd. to analyse iPSC (induced Pluripotent Stem Cell) samples from 7 of Europe’s leading centres for iPSC production.
Glasgow, Scotland. With the aim of improving clinical outcome in cancer patients, TC BioPharm (TCB) and Sistemic will work together to develop a range of biomarkers designed to provide valuable information on individual patient responses to TCB’s innovative cell therapy product.
Glasgow, Scotland Sistemic Ltd announced today that the company had been short-listed as one of the top 10 companies to watch in the developing stem cell sector by the well regarded digest StemCellAssays.